Pharma Exclusives Pressreleases
Moderna Announces Global Regulatory Submissions for Its Investigational Seasonal Influenza Vaccine
Monday, January 05, 2026Moderna Inc today provided an update on regulatory submissions for its investigational seasonal influenza vaccine mRNA for adults aged years and older The Company has filed for marketing authorization with the US Food and Drug Administration FDA
Gilead Sciences Exercises Option to License Assembly Biosciences’ Helicase-Primase Inhibitor Programs for Recurrent Genital Herpes
Monday, December 22, 2025Gilead Sciences Inc and Assembly Biosciences Inc Nasdaq ASMB today announced Gilead has exercised its combined option to exclusively license Assembly Bios herpes simplex virus HSV
Thermo Fisher Scientific Expands Gibco™ Bacto™ Portfolio with Next-Generation, Chemically Defined Media to Boost E. coli Biomanufacturing Productivity
Monday, December 15, 2025Thermo Fisher Scientific Inc the world leader in serving science today announced the launch of Gibco Bacto CD Supreme FPM Plus and Gibco Bacto CD Supreme Feed X two nextgeneration chemicallydefined formulations that expand the Gibco Bacto
Lilly to build $6 billion facility to manufacture active pharmaceutical ingredients in Alabama
Wednesday, December 10, 2025Eli Lilly and Company today announced plans to invest more than billion in a new manufacturing facility in Huntsville Alabama This nextgeneration synthetic medicine active pharmaceutical ingredient API facility the third of four new US
Imfinzi approved in the US as first and only perioperative immunotherapy for patients with early gastric and gastroesophageal cancers
Wednesday, November 26, 2025AstraZenecas Imfinzi durvalumab in combination with standardofcare FLOT chemotherapy fluorouracil leucovorin oxaliplatin and docetaxel has been approved in the US for the treatment of adult patients with resectable
AstraZeneca plans $2 billion manufacturing investment in Maryland, supporting 2,600 jobs and catalysing economic growth
Monday, November 24, 2025AstraZeneca today announces plans to invest billion to expand its longstanding manufacturing footprint in Maryland This includes a significant expansion of its flagship biologics manufacturing facility in Frederick and construction
Biogen and Dayra Therapeutics Announce Research Collaboration to Discover and Develop Oral Macrocyclic Peptides for a Range of Immunological Conditions
Monday, November 24, 2025Biogen Incand Dayra Therapeutics today announced a research collaboration to discover and develop oral macrocyclic peptides for priority targets in immunological conditions Macrocyclic peptides have a unique profile with the potential to offer biolog...
AbbVie Partners with Award-Winning Filmmaker on Film About the Dynamic and Resilient Lives of Those Living with Blood Cancer
Saturday, November 15, 2025AbbVieannounced today the launch of Second Winds a new short film that captures the powerful deeply personal journeys of three people living with chronic lymphoma leukemia CLL a common type of blood cancer effecting hundreds
Pfizer Completes Acquisition of Metsera
Friday, November 14, 2025Pfizer Inctoday announced the successful completion of its acquisition of Metsera Inca clinicalstage biopharmaceutical company accelerating the next generation of medicines for obesity and cardiometabolic diseases
TrakCel introduces CGT Gateway to revolutionize access to cell & gene therapies for healthcare professionals
Thursday, November 13, 2025TrakCel a leading provider of integrated cell and gene therapy CGT orchestration solutions has today launched CGT Gateway to help Health Care Providers HCPs ease the management of cell and gene therapy products
